Rethinking High-Risk Acute Promyelocytic Leukemia: A Landmark Meta-Analysis Challenges Decades of Intensive Chemotherapy Dogma
Executive Overview Acute promyelocytic leukemia (APL) has long been considered one of the great success stories of modern hematology, with standard-risk patients routinely achieving cure rates exceeding 90% via targeted…